Abstract
Intuitive Machines will report quarterly results on May 14, 2026 Pre-Market; this preview reviews last quarter’s revenue, margins, and adjusted EPS, and evaluates the current quarter’s projections and consensus tone using company guidance, market forecasts, and recent analyst commentary.Market Forecast
Based on the latest projections, Intuitive Machines’ current quarter revenue is estimated at 202.68 million US dollars, implying year-over-year growth of 214.36%, with adjusted EPS projected at -0.073, implying a 14.28% year-over-year improvement; EBIT is forecast at -12.36 million US dollars, a year-over-year change of -11.86%. Forecasts for gross margin and net margin are not available; investors remain focused on operating leverage as revenue scales.Management’s execution roadmap emphasizes a step-change in lunar services activity and related contract milestones this quarter, with a stronger mix of fixed‑price program deliveries. The most promising revenue driver appears to be fixed‑price contracts at 120.31 million US dollars in the recent mix, positioned to capture the forecast 214.36% year-over-year top-line increase as milestone billings convert.
Last Quarter Review
In the prior quarter, Intuitive Machines reported revenue of 44.79 million US dollars, a gross profit margin of 18.95%, GAAP net loss attributable to the parent of 34.93 million US dollars, a net margin of -78.00%, and adjusted EPS of -0.32; revenue fell 18.07% year-over-year while adjusted EPS improved 86.83% year-over-year. Quarter-on-quarter, GAAP net profit contracted by -239.56%, underscoring the sensitivity of profitability to mission timing and cost phasing.A notable financial detail was the company’s efficiency progress on project cost curves, which supported an 18.95% gross margin despite the revenue dip versus last year. In terms of revenue composition, recent-period contributions were concentrated in fixed‑price contracts (120.31 million US dollars), reimbursable expenses (80.10 million US dollars), time‑and‑materials (6.72 million US dollars), and grants (2.93 million US dollars), highlighting a milestone‑driven revenue profile.
Current Quarter Outlook
Main business: Contracted mission execution and milestone conversions
The company’s near-term financial path hinges on converting contracted milestones into revenue at scale, reflected in the 202.68 million US dollars revenue estimate and implied 214.36% year-over-year growth for this quarter. The operating model remains milestone‑dependent, so the timing of customer acceptance and technical checkpoints will drive top-line recognition and margin cadence. With the prior quarter’s gross margin at 18.95%, incremental volume could improve operating leverage, though mix and mission cadence will determine how much of that flows to gross profit.Visibility in the latest forecast is anchored by fixed‑price program deliveries and reimbursable contract work. Fixed-price milestones, in particular, can accelerate revenue recognition and support margin if execution costs track to plan. Investors should also monitor the magnitude and pace of reimbursable billings; while less margin‑accretive, they provide cash conversion and sustain the operating cycle. The EBIT estimate of -12.36 million US dollars signals the business is not yet through the inflection point, but the EPS estimate of -0.073 indicates sequential progress is expected as revenue scales.
Most promising business: Fixed-price contracts and mission milestones
Fixed‑price contracts, at 120.31 million US dollars in the latest mix disclosure, are positioned as the core incremental driver this quarter given the milestone schedule and associated delivery scope. This revenue type typically concentrates earnings recognition around technical completions and customer acceptances, making quarter outcomes sensitive to schedule but leverageable when milestones cluster. The company-level revenue forecast implies 214.36% year-over-year growth, and fixed‑price programs are expected to be the primary contributor to that step-up.Operationally, cost discipline on fixed‑price scopes is crucial. Any deviation—such as additional testing, rework, or part shortages—can compress contract economics and flow through to EBIT and EPS. Conversely, on-time deliveries create a favorable margin mix relative to reimbursable work, allowing gross profit to expand faster than revenue when milestone density is high. The path to narrowing losses suggested by the EPS estimate depends on sustaining that execution rhythm without significant cost leakage.
Key stock-price swing factor: Mission timing, technical outcomes, and capital signals
The market’s reaction this quarter is likely to be most sensitive to three elements: the timing of mission milestones, the technical outcomes associated with those milestones, and any signals on funding or liquidity runway. The net margin of -78.00% in the previous quarter illustrates the earnings sensitivity to schedule and outcome; a concentrated cluster of accepted milestones can reverse that picture rapidly, while delays can push revenue to subsequent periods. This quarter’s large revenue estimate implies a heavier milestone calendar; delivery verification and post‑event debriefs will influence both margins and sentiment.Technical outcomes—particularly for lunar deliveries and related hardware—feed directly into confidence in the backlog-to-revenue conversion. Recent headlines around lander posture and mission learnings increased volatility earlier in the year; the current quarter offers a tangible test of operational improvements and risk controls. Positive outcomes and clear learnings can strengthen confidence in near-term guidance and the projected trajectory toward improving adjusted profitability. On the capital side, any update on grants, awards, or customer prepayments can de-risk the burn implied by the EBIT forecast and support execution throughput.
Analyst Opinions
Across recent commentary, the majority stance skews cautiously optimistic rather than negative, with rating notes maintaining favorable views while trimming targets and acknowledging execution risk. One investment banking note reaffirmed a Buy rating while adjusting the target price modestly lower (from 22.00 to 21.00 US dollars), signaling continued support for the equity case with recognition of volatility around milestones and mission cadence. Broader market commentary also flagged positive developments such as a grant selection of up to 10.00 million US dollars for an Earth reentry vehicle initiative, which, while not a substitute for scaled revenue, provides incremental non-dilutive funding and validates development pathways tied to near-term deliverables.On balance, bullish viewpoints outnumber bearish ones in the recent period: positive ratings and incremental funding news counterweigh interim share price drawdowns tied to mission posture updates earlier in the year. Supportive opinions emphasize the anticipated revenue step-up this quarter—202.68 million US dollars with a projected 214.36% year-over-year increase—and a path to improved adjusted EPS from -0.32 last quarter to an estimated -0.073. The constructive camp argues that the business remains milestone‑weighted, so quarter-to-quarter variability should be assessed in the context of multi‑mission execution, with fixed‑price conversions expected to dominate near-term revenue mix and drive leverage when schedules hold.
The optimistic view also points to company guidance from recent filings that outlined a plan for materially higher revenue in 2025 and a progression toward improved adjusted EBITDA metrics over time. In this reading, the present quarter serves as a validation checkpoint for scaling revenue recognition while narrowing losses. Analysts adopting this stance focus on three tests: the density and acceptance timing of milestones this quarter relative to plan, evidence of gross margin stability around the 18–19% zone as volume accelerates, and the degree to which cash inflows from reimbursable work and grants buffer the EBIT forecast of -12.36 million US dollars.
Cautious bulls acknowledge that setbacks earlier in the year increased headline risk, which can compress the valuation window even if revenue lands close to estimates. They highlight, however, that fixed‑price programs historically unlock disproportionate bottom‑line improvement when milestone clusters are met, raising the potential for upside to adjusted EPS relative to the -0.073 estimate if execution outperforms. A minority of more guarded voices continue to focus on downside scenarios—slippage of critical milestones or additional technical remediation pushing recognition into later periods—but currently those views are outnumbered by supportive ratings and constructive previews.
Overall, the majority perspective expects a pronounced sequential and year-over-year revenue ramp this quarter, improving adjusted EPS, and a narrative increasingly shaped by milestone conversion pace rather than demand. The balance of commentary frames this print as a pivotal data point for assessing operating leverage and the company’s ability to translate backlog into financial progress, keeping attention squarely on fixed‑price milestone deliveries and the corroborating margin and cash signals they produce.